ASCANI S; SABATTINI E; AGOSTINELLI C; PICCALUGA PP; ZINZANI P.; PILERI SA, Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome, «HAEMATOLOGICA», 2004, 89 (4), pp. EIM07 - EIM07 [Scientific article]Open Access
ZINZANI P.; PULSONI A; PERROTTI A; SOVERINI S; ZAJA F; DE RENZO A; STORTI S; LAUTA VM; GUARDIGNI L; GENTILINI P; TUCCI A; MOLINARI AL; GOBBI M; FALINI B; FATTORI PP; CICCONE F; ALINARI L; MARTELLI M; PILERI S; TURA S; BACCARANI M., Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma., «JOURNAL OF CLINICAL ONCOLOGY», 2004, 22, pp. 2654 - 2661 [Scientific article]
ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M., Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma., «CANCER», 2004, 100, pp. 2190 - 2194 [Scientific article]
SOLAL-CELIGNY P; ROY P; COLOMBAT P; WHITE J; ARMITAGE JO; ARRANZ-SAEZ R; AU WY; BELLEI M; BRICE P; CABALLERO D; COIFFIER B; CONDE-GARCIA E; DOYEN C; FEDERICO M; FISHER RI; GARCIA-CONDE JF; GUGLIELMI C; HAGENBEEK A; HAIOUN C; LEBLANC M; LISTER AT; LOPEZ-GUILLERMO A; MCLAUGHLIN P; MILPIED N; MOREL P; MOUNIER N; PROCTOR SJ; ROHATINER A; SMITH P; SOUBEYRAN P; TILLY H; VITOLO U; ZINZANI P.; ZUCCA E; MONTSERRAT E., Follicular lymphoma international prognostic index., «BLOOD», 2004, 104, pp. 1258 - 1265 [Scientific article]
ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M.; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M., High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience, «LEUKEMIA & LYMPHOMA», 2004, 45 (2), pp. 321 - 326 [Scientific article]
PILERI SA; SABATTINI E; AGOSTINELLI C; BODEGA L; ROSSI M; ZINZANI P.; MARAFIOTI T., Histopathology of B-cell chronic lymphocytic leukemia., «HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA», 2004, 18, pp. 807 - 826 [Scientific article]
PILERI SA; ZINZANI P.; WENT P; PILERI A JR; BENDANDI M, Indolent lymphoma: the pathologist's viewpoint, «ANNALS OF ONCOLOGY», 2004, 15 (1), pp. 12 - 18 [Scientific article]
Marafioti T.; Mancini C.; Ascani S.; Sabattini E.; Zinzani P.L.; Pozzobon M.; Pulford K.; Falini B.; Jaffe E.S.; Müller-Hermelink H.K.; Mason D.Y.; Pileri S.A., Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin’s disease., «HAEMATOLOGICA», 2004, 89, pp. 957 - 964 [Scientific article]
ZINZANI PL; TANI M; MARCHI E; STEFONI V; ALINARI L; MUSURACA G; GABRIELE A; PILERI S; BACCARANI M., Long-term follow-up of front-line treatment of hairy cell leukemia with
2-chlorodeoxyadenosine, «HAEMATOLOGICA», 2004, 89 (3), pp. 309 - 313 [Scientific article]
WENT P; ASCANI S; STROM E; BRORSON SH; MUSSO M; ZINZANI P.; FALINI B; DIRNHOFER S; PILERI S., Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease., «THE LANCET ONCOLOGY», 2004, 5, pp. 381 - 383 [Scientific article]
ZINZANI PL; FANTI S; BATTISTA G; TANI M; CASTELLUCCI P; STEFONI V; ALINARI L; FARSAD M; MUSURACA G; GABRIELE A; MARCHI E; NANNI C; CANINI R.; MONETTI N; BACCARANI M, Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients., «BRITISH JOURNAL OF CANCER», 2004, 91 (5), pp. 850 - 854 [Scientific article]
E. BARBIERI; S. CAMMELLI; F. MAURO; F. PERINI; CAZZOLA A.; S. NERI; F. BUNKHEILA; S. FERRARI; V. BRANDOLI; P. ZINZANI; M. MERCURI; G. BACCI, Primary non-hodgkin’s lymphoma of bone: treatment and analysis of prognostic factors for stage I and stage II, «INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS», 2004, 59, pp. 760 - 764 [Scientific article]
GOBBI PG; BROGLIA C; DI GIULIO G; MANTELLI M; ANSELMO P; MERLI F; ZINZANI P.; ROSSI G; CALLEA V; IANNITTO E; PAULLI M; GARIONI L; ASCARI E., The clinical value of tumor burden at diagnosis in Hodgkin lymphoma., «CANCER», 2004, 101, pp. 1824 - 1834 [Scientific article]
POLITO L.; BOLOGNESI A.; TAZZARI P. L.; FARINI V.; LUBELLI C.; ZINZANI P. L.; RICCI F.; STIRPE F., The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20 expressing cells and produces a synergistic toxic effect with Fludarabine, «LEUKEMIA», 2004, 18, pp. 1215 - 1222 [Scientific article]
CASTELLUCCI P; ZINZANI P; NANNI C; FARSAD M; MORETTI A; ALINARI L; BATTISTA G; PETTINATO C; MARENGO M; BOSCHI S; CANINI R; BACCARANI M.; MONETTI N; FANTI S., 18F-FDG PET early after radiotherapy in lymphoma patients., «CANCER BIOTHERAPY & RADIOPHARMACEUTICALS», 2004, 19, pp. 606 - 612 [Scientific article]
